Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Avience BiomedicalsNSE:AVIENCE +1.17%18 Days Inventory is 171.73 as of Mar. 2025, which is at its 10-year median of 171.73. GuruFocus rates NSE:AVIENCE with a GF Score™ of 18/100. The stock has 3 warning signs investors should review. Among 787 Medical Devices & Instruments companies, Avience Biomedicals ranks better than 52.48% on this metric.
The historical rank and industry rank for Avience Biomedicals's Days Inventory or its related term are showing as below:
NSE:AVIENCE'
s Days Inventory Range Over the Past 10 Years
Min: 166.25 Med: 171.73 Max: 186.61
Current: 171.73
During the past 3 years, Avience Biomedicals's highest Days Inventory was 186.61. The lowest was 166.25. And the median was 171.73.
NSE:AVIENCE's Days Inventory is ranked better than 52.48% of 787
companies
in the Medical Devices & Instruments industry
Industry Median: 176.75
vs NSE:AVIENCE: 171.73
Avience Biomedicals's Days Inventory
increased
from Mar. 2023 (166.25) to Mar. 2025 (171.73).
It might indicate that Avience Biomedicals's sales slowed down.
Warning Sign:
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Avience Biomedicals's Inventory Turnover for the
six
months ended in Mar. 2025 was 2.13.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Avience Biomedicals's Inventory-to-Revenue for the
six
months ended in Mar. 2025 was 0.28.
Avience Biomedicals (NSE:AVIENCE) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Avience Biomedicals's Inventory Turnover for the
six
months ended in Mar. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Avience Biomedicals's Inventory to Revenue for the
six
months ended in Mar. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Avience Biomedicals Days Inventory Related Terms
Avience Biomedicals Days Inventory Historical Data
* Premium members only.
The historical data trend for Avience Biomedicals's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Avience Biomedicals Days Inventory Chart
Avience Biomedicals Annual Data
Trend
Mar23
Mar24
Mar25
Days Inventory
166.25
186.61
171.73
Avience Biomedicals Semi-Annual Data
Mar23
Mar24
Mar25
Days Inventory
166.25
186.61
171.73
NSE:AVIENCE vs ABT, SYK, MDT: Days Inventory Comparison
For the Medical Devices subindustry, Avience Biomedicals's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Avience Biomedicals Days Inventory vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Avience Biomedicals's Days Inventory distribution charts can be found below:
* The bar in red indicates where Avience Biomedicals's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Avience Biomedicals (NSE:AVIENCE) has a Days Inventory of 171.73 as of Mar. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Avience Biomedicals and its competitors. This is near median its historical median of 171.73. Over the past decade, Avience Biomedicals' Days Inventory has ranged from 166.25 to 186.61. According to the industry distribution chart, Avience Biomedicals ranks #374 out of 787 companies in the Medical Devices & Instruments industry, placing it in the top 47.5%.
Is Avience Biomedicals' Days Inventory too high?
Avience Biomedicals' current Days Inventory of 171.73 is near median its 10-year median of 171.73. Over the past 10 years, this metric has ranged from a low of 166.25 to a high of 186.61. The Medical Devices & Instruments industry median Days Inventory is 176.75. Avience Biomedicals' value of 171.73 is 2.8% below this industry median. Based on the distribution chart, Avience Biomedicals ranks #374 out of 787 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Avience Biomedicals has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Avience Biomedicals' Days Inventory compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Avience Biomedicals ranks #374 out of 787 companies for Days Inventory. This puts Avience Biomedicals in the upper half of its industry. The industry median Days Inventory is 176.75. Avience Biomedicals' value of 171.73 is 2.8% below this benchmark. Historically, Avience Biomedicals' own Days Inventory has ranged from 166.25 to 186.61 over the past decade. While the company's 10-year median is 171.73 vs. the industry median of 176.75, Avience Biomedicals has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Devices & Instruments company?
The median Days Inventory among Medical Devices & Instruments companies is 176.75, based on 787 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Avience Biomedicals's current Days Inventory of 171.73 is 2.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Avience Biomedicals and its competitors. For the Medical Devices & Instruments industry, the median Days Inventory is 176.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Avience Biomedicals's current Days Inventory is 171.73, which is near median its own 10-year median of 171.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avience Biomedicals stock overvalued right now?
Avience Biomedicals (NSE:AVIENCE) has a current Days Inventory of 171.73. The current Days Inventory is 171.73, which is near median its 10-year median of 171.73 and 2.8% below the Medical Devices & Instruments industry median of 176.75. Avience Biomedicals' overall GF Score™ is 18/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Avience Biomedicals (NSE:AVIENCE), the current Days Inventory is 171.73 as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Avience Biomedicals Ltd is a medical consumables company focused on the manufacturing of Vitro-Diagnostic (IVD) products and medical devices. Its product offerings include diagnostic solutions used for the detection of diseases, conditions, and infections across laboratory, healthcare, and home-use applications. The company operates in areas including molecular biotechnology, genomics, and diagnostic products, and also provides distribution services for medical technology products in India. Its revenue is generated from Manufactured Goods and Traded Goods and Services, which include the sale of Medical Devices and Consumables.
18GF Score
Get the complete analysis for NSE:AVIENCE
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:AVIENCE has been successfully added to your 
